Archived This bill is from the 117th Congress (2021–2022) and is no longer under active consideration.
Bills/H.Res. 1274117th Congress

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

House: Reported
Cosponsors
1
Introduced
2022-07-26
Last action
2022-09-29

Placed on the House Calendar, Calendar No. 133.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Placed on the House Calendar, Calendar No. 133.

  2. House

    Reported by the Committee on Energy and Commerce. H. Rept. 117-527.

  3. House

    Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.

  4. House

    Committee Consideration and Mark-up Session Held.

  5. House

    Subcommittee on Health Discharged.

  6. House

    Referred to the Subcommittee on Health.

  7. House

    Referred to the House Committee on Energy and Commerce.

  8. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Topics

Policy area

Sign in to view Hilltelligence’s potential-cosponsor analysis.